Integra LifeSciences – Limit Uncertainty

1140 Words3 Pages

Integra LifeSciences – Limit Uncertainty
Integra LifeSciences (IART) is a multinational corporation providing medical devices supporting wide array of surgical needs. Their strategic intent is to become the worldwide leader in in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. Their innovative offerings and growth through acquisition has allowed them to become a billion dollar enterprise since their inception in 1989 (“IART profile”). They are headquartered in Plainsboro, New Jersey and have 3,300 employees worldwide (“Company profile,” 2014). Integra's common stock is listed on The NASDAQ Stock Market under the symbol "IART." Integra’s target markets reside in the United States, European Union, Asia Pacific, BRIC (Brazil, Russia, India and China) and Latin America.
Integra's business model is matrix broken down into divisions supporting extremities, spine, neurosurgery, and international. This allows them to focus on core competencies while responding to local needs. Their broad portfolio of products include orthopedics, implants and hospital equipment used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Integra’s primary markets are within the U.S., where approximately 75% of revenue is generated (“Integra lifesciences reports,” 2014).
Integra’s growth from 1989 through 2014 has been driven using an acquisition model. During this time, Integra has completed over 40 acquisitions. This model has limited organic growth as most of their new product introductions surround derivative improvements of existing products. Their most recent acquisition was their largest. They consummated a deal with Covidien to acquire DuraSeal for $235 million in...

... middle of paper ...

...ant System. Retrieved May 3, 2014, from http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm185478.htm
Gerber, J. (2011). International economics. (5th ed.). Upper Saddle River, NJ: Prentice
IART Profile. (n.d.). . Retrieved May 3, 2014, from http://finance.yahoo.com/q/pr?s=IART+Profile
Integra LifeSciences Completes Acquisition of DuraSeal Product Lines From Covidien. (January 15, 2014). . Retrieved May 2, 2014, from http://globenewswire.com/news-release/2014/01/15/602722/10064277/en/Integra-LifeSciences-Completes-Acquisition-of-DuraSeal-Product-Lines-From-Covidien.html
Integra LifeSciences Reports First Quarter 2014 Financial Results. (May 1, 2014). MarketWatch. Retrieved May 3, 2014, from http://www.marketwatch.com/story/integra-lifesciences-reports-first-quarter-2014-financial-results-2014-05-01

Open Document